✦ LIBER ✦

VA.3 Adjuvant treatment in elderly breast cancer patients – Interim safety analysis of the ICE study

✍ Scribed by von Minckwitz, G.

Book ID: 122420869
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 46 KB
Volume: 60
Category: Article
ISSN: 1040-8428
DOI: 10.1016/S1040-8428(13)70040-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P323 Second interim analysis of dose den

P323 Second interim analysis of dose density with zoledronic acid treatment in metastatic breast cancer patients. ZARAS study

✍ A. Rodríguez-Lescure; J. de la Haba; J. Baena; J. Martin; S. Morales; J. Chacon; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

First interim results of an ongoing stud

First interim results of an ongoing study comparing the GNRH-agonist leuprorelinacetate and CMF as adjuvant treatment in premenopausal breast cancer

✍ M. Untch; K. Possinger; L. Vasiljew 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Safety and tolerability of FOLFOX4 in th

Safety and tolerability of FOLFOX4 in the adjuvant treatment of colon cancer in Asian patients: The MASCOT study

✍ Po-Huang LEE; Young-Suk PARK; Jia-Fu JI; Yiu-Tung FU; Vorachai RATANATHARATHORN 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Bi-weekly docetaxel in the adjuvant trea

Bi-weekly docetaxel in the adjuvant treatment of node-positive or high-risk breast cancer patients: phase I study of the Shiga Breast Cancer Study Group

✍ Hajime Abe; Hiroki Ogawa; Takashi Okino; Makoto Kato; Hirotaka Sako; Haruo Sano; 📂 Article 📅 2008 🏛 Springer Japan 🌐 English ⚖ 150 KB

Adjuvant treatments do not alter the qua

Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer : A population-based study

✍ Anne-Marie Bouvier; Valérie Jooste; Franck Bonnetain; Vanessa Cottet; Marie-Hélè 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB 👁 2 views

PP-5-16 A Study of Postoperative Adjuvan

PP-5-16 A Study of Postoperative Adjuvant Chemotherapy of 5′-DFUR in Breast Cancer Patients (1st Report) — On Compliance and Safety — “The 5′-BC Study Group” (5′-DFUR Adjuvant Chemotherapy for Breast Cancer Study Group)

✍ H. Koyama; O. Abe; J. Uchino; W. Hayasaka; R. Abe; M. Izuo; K. Enomoto; T. Tomin 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 172 KB